Areas of Application
The sodium iodide (131I)
is a radiopharmaceutical used in nuclear
medicine for diagnosing and treating
thyroid cancer and its metastases
Specifi cation
The one-stage thermographic technology
has been developed for the extraction
of 131I from tellurium irradiated by neutrons
from WWR-M research reactor of INR
of the NAS of Ukraine. 131I output from
the target material exceeds 70%. The fi nal
product is carrier-free sodium iodide (131I)
solution dispersed on the surface of solid inert
carrier contained in gelatin capsules.
The physical and chemical properties
of sodium iodide (131I) meet the requirements
of the European Pharmacopoeia.
Radioactive Concentration, ÐœBq/ml 37-1100
Radionuclide purity, %
99.99
>97
Radiochemical purity, %
Chemical purity, ррm Те
<1
Acidity, Ñ€Ð
7-10
Advantages
There are no counterparts
in Ukraine; cheaper than
the foreign analogs
Stage of Development.
Suggestion for Commercialization
IRL4, TRL4
Manufactured and supplied,
upon request
IPR Protection
IPR1
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"
